当前位置：
X-MOL 学术
›
Biotechnol. Prog.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Development of a high cell density transient CHO platform yielding mAb titers greater than 2 g/L in only 7 days
Biotechnology Progress ( IF 2.5 ) Pub Date : 2020-07-12 , DOI: 10.1002/btpr.3047 Matthew G Schmitt 1 , Regina N White 1 , Gavin C Barnard 1
Biotechnology Progress ( IF 2.5 ) Pub Date : 2020-07-12 , DOI: 10.1002/btpr.3047 Matthew G Schmitt 1 , Regina N White 1 , Gavin C Barnard 1
Affiliation
We developed a simple transient Chinese Hamster Ovary expression platform. Titers for a random panel of 20 clinical monoclonal antibodies (mAbs) ranged from 0.6 to 2.7 g/L after 7 days. Two factors were the key in obtaining these high titers. First, we utilized an extremely high starting cell density (20 million cells/ml), and then arrested further cell growth by employing mild hypothermic conditions (32°C). Second, we performed a 6‐variable Design of Experiments to find optimal concentrations of plasmid DNA (coding DNA), boost DNA (DNA encoding the XBP1S transcription factor), transfection reagent (polyethylenimine [PEI]), and nutrient feed amounts. High coding DNA concentrations (12.5 mg/L) were found to be optimal. We therefore diluted expensive coding DNA with inexpensive inert filler DNA (herring sperm DNA). Reducing the coding DNA concentration by 70% from 12.5 to 3.75 mg/L did not meaningfully reduce mAb titers. Titers for the same panel of 20 clinical mAbs ranged from 0.7 to 2.2 g/L after reducing the coding DNA concentration to 3.75 mg/L. Finally, we found that titer and product quality attributes were similar for a clinical mAb (rituximab) expressed at very different scales (volumes ranging from 3 ml to 2 L).
更新日期：2020-07-12
京公网安备 11010802027423号